Table 2.
Cross-Validated Efficiency, Defined as the Rate of Positive Predictions (Proportion of the Population Flagged as High Risk) to Achieve a Fixed Sensitivity for Correct Classification of Seroconversions (Top); and Cross-Validated Sensitivity That Would Have Been Achieved When Fixing the Rate of Positive Predictions (Bottom)
| Rate of Positive Predictions, % | |||
|---|---|---|---|
| Needed to meet a minimum sensitivity, % | Risk Groupa | Model-based | Machine Learning |
| 50 | 42 | 27 | 18 |
| 60 | NA | 39 | 26 |
| 70 | NA | 51 | 37 |
| 80 | NA | 63 | 48 |
| Sensitivity Achieved, % | |||
| Limiting the rate of positive predictions, % | Risk Groupb | Model-based | Machine Learning |
| 20 | 8 | 40 | 52 |
| 30 | 8 | 55 | 65 |
| 40 | 8 | 68 | 74 |
| 45 | 58 | 68 | 78 |
Abbreviation: NA, not applicable.
aA strategy to target all persons with at least 1 known risk factor (score ≥ 1) would have offered intensified prevention to 42% of the population; a lower threshold (score ≥ 0) is NA.
bA strategy to target all persons with at least 2 known risk factors (score ≥ 2) would have achieved 8% sensitivity, while a strategy to target all persons with at least 1 known risk factor (score ≥ 1) would have achieved 58% sensitivity.